NovoCure (NVCR) EBT (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.11% |
| Dec 31, 2025 | -36.41% |
| Sep 30, 2025 | 14.17% |
| Jun 30, 2025 | -15.46% |
| Mar 31, 2025 | 45.12% |
| Dec 31, 2024 | -155.76% |
| Sep 30, 2024 | 5.03% |
| Jun 30, 2024 | 28.17% |
| Mar 31, 2024 | 17.89% |
| Dec 31, 2023 | 20.09% |
| Sep 30, 2023 | 10.54% |
| Jun 30, 2023 | -5.53% |
| Mar 31, 2023 | -56.89% |
| Dec 31, 2022 | -39.04% |
| Sep 30, 2022 | -0.26% |
| Jun 30, 2022 | -828.67% |
| Mar 31, 2022 | 90.17% |
| Dec 31, 2021 | -142.79% |
| Sep 30, 2021 | 20.42% |
| Jun 30, 2021 | -384.09% |
| Mar 31, 2021 | -130.98% |
| Dec 31, 2020 | -20.06% |
| Sep 30, 2020 | 172.50% |
| Jun 30, 2020 | 169.69% |
| Mar 31, 2020 | -265.14% |
| Dec 31, 2019 | -222.46% |
| Sep 30, 2019 | 3,123.26% |
| Jun 30, 2019 | 99.49% |
| Mar 31, 2019 | 21.57% |
| Dec 31, 2018 | -41.62% |
| Sep 30, 2018 | 23.15% |
| Jun 30, 2018 | 43.27% |
| Mar 31, 2018 | -154.43% |
| Dec 31, 2017 | 14.67% |
| Sep 30, 2017 | 54.41% |
| Jun 30, 2017 | -11.97% |
| Mar 31, 2017 | -126.26% |
| Dec 31, 2016 | 297.81% |
| Sep 30, 2016 | 19.42% |
| Jun 30, 2016 | -16.33% |
| Mar 31, 2016 | -3.20% |
| Dec 31, 2015 | -25.68% |
| Sep 30, 2015 | 10.81% |
| Jun 30, 2015 | -24.60% |
| Mar 31, 2015 | -163.98% |
| Dec 31, 2014 | 296.14% |